Cholesterol excess Levure de riz rouge Commiphora Policosanol Q10
Food supplement declared in France, declaration No 2019-7-514, decision dated 10 July 2019
Cholesterol excess Levure de riz rouge Commiphora Policosanol Q10 (HERBORISTERIE DE PARIS) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Commiphora mukul 500 mg per day, Monascus purpureus 450 mg per day, Ubiquinone, Policosanols. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- HERBORISTERIE DE PARIS
- Food business operator placing the product on the market
- Herborisa Natura sarl
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 4 gélules par jour
- Directions for use
- voir mode d'emploi dans rubrique mise en garde et avertissemnt
- Intended populations
- People over 60, Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Kidney disease, Infants (under 1 year), Liver problems, Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Arteries and cholesterol
Declaration 213889, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Commiphora mukul Engl. | Résine | Extrait sec hydroalcoolique | 500 mg |
| Monascus purpureus Went | Graine | Poudre (de plantes séchées ou broyées) | 450 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Ubiquinone | not declared |
| Policosanols | not declared |
Additives
E470b
Other ingredients
gélatine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
4 gélules par jour réparties en 2 prises soit 2 le midi et 2 le soir avec un grand verre d'eau au cours des repas Déconseillé aux femmes enceintes ou allaitantes, les enfants et adolescents, les personnes ayant des problèmes hépatiques, rénaux ou musculaires, les personnes intolérantes aux statitines ou hypertendues. Déconseillé en cas de prise de médicaments hypolipémiants ou de consommation concomitante de pamplemousse (jus ou fruit)
Regulatory points
- Conditions légales
Contains red yeast rice. Monacolins must remain below 3 mg per daily portion, with mandatory warnings on the label. The monacolin content is not declared in Compl'Alim.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie B (règlement (UE) 2022/860).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : HERBORISTERIE DE PARIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Cholesterol excess Levure de riz rouge Commiphora Policosanol Q10 (HERBORISTERIE DE PARIS): composition and regulation”, https://compoatlas.com/en/supplements/products/213889-cholesterol-excess-levure-de-riz-rouge-commiphora-policosano, updated 15 November 2026.